Skip to main navigation Skip to search Skip to main content

Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease

  • Satoshi Yoshiji*
  • , Tianyuan Lu
  • , Guillaume Butler-Laporte
  • , Julia Carrasco-Zanini-Sanchez
  • , Chen-Yang Su
  • , Yiheng Chen
  • , Kevin Liang
  • , Julian Daniel Sunday Willett
  • , Shidong Wang
  • , Darin Adra
  • , Yann Ilboudo
  • , Takayoshi Sasako
  • , Satoshi Koyama
  • , Tetsushi Nakao
  • , Vincenzo Forgetta
  • , Yossi Farjoun
  • , Hugo Zeberg
  • , Sirui Zhou
  • , Michael Marks-Hultström
  • , Mitchell J. Machiela
  • Rama Kaalia, Hesam Dashti, Melina Claussnitzer, Jason Flannick, Nicholas J. Wareham, Vincent Mooser, Nicholas J. Timpson, Claudia Langenberg, J. Brent Richards*
*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

34 Citations (Scopus)

Abstract

Obesity strongly increases the risk of cardiometabolic diseases, yet the underlying mediators of this relationship are not fully understood. Given that obesity strongly influences circulating protein levels, we investigated proteins mediating the effects of obesity on coronary artery disease, stroke and type 2 diabetes. By integrating two-step proteome-wide Mendelian randomization, colocalization, epigenomics and single-cell RNA sequencing, we identified five mediators and prioritized collagen type VI α3 (COL6A3). COL6A3 levels were strongly increased by body mass index and increased coronary artery disease risk. Notably, the carboxyl terminus product of COL6A3, endotrophin, drove this effect. COL6A3 was highly expressed in disease-relevant cell types and tissues. Finally, we found that body fat reduction could reduce plasma levels of COL6A3-derived endotrophin, indicating a tractable way to modify endotrophin levels. In summary, we provide actionable insights into how circulating proteins mediate the effects of obesity on cardiometabolic diseases and prioritize endotrophin as a potential therapeutic target.
Original languageEnglish
Article number1279
Pages (from-to)345-357
Number of pages13
JournalNature Genetics
Volume57
Issue number2
Early online date24 Jan 2025
DOIs
Publication statusPublished - 1 Feb 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease'. Together they form a unique fingerprint.

Cite this